Dysport Related Published Studies
Well-designed clinical trials related to Dysport (Botulinum Toxin Type A)
Botulinum toxin injection for hypertonicity of the upper extremity within 12
weeks after stroke: a randomized controlled trial. [2012]
Immunoresistance in cervical dystonia patients after treatment with
abobotulinumtoxinA. [2012]
Prospective randomized comparison of onabotulinumtoxinA (Botox) and
abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and
periorbital wrinkles. [2012]
Effectiveness of type A botulinum toxins for aesthetic indications and their
relative economic impact. [2012]
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. [2012]
Botulinum toxin effects on gasatrocnemius strength and plantar pressure in
diabetics with peripheral neuropathy and forefoot ulceration. [2012]
Modification of altered ankle motor control after stroke using focal application
of botulinum toxin type A. [2012]
Vandetanib: in medullary thyroid cancer. [2012]
Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a
randomised blinded placebo-controlled trial of 240 women (the RELAX study). [2012]
Topical diltiazem cream versus botulinum toxin a for the treatment of chronic
anal fissure: a double-blind randomized clinical trial. [2012]
[Treatment of crow's feet with two different botulinum toxin type A preparations in split-face technique]. [2011.05]
Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. [2011.02.01]
Prophylactic botulinum type A toxin complex (Dysport(R)) for migraine without aura. [2011.01]
Time to onset of response of abobotulinumtoxina in the treatment of glabellar
lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type
A. [2011]
Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura. [2011]
Implications of current clinical trials focused on medication overuse and
therapeutic prophylaxis. [2011]
The safety and efficacy of botulinum toxin-A in the management of bladder
oversensitivity: a randomised double-blind placebo-controlled trial. [2011]
Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD
pain: a randomized, controlled, double-blind multicenter study. [2011]
[Botulinum toxin and painful peripheral neuropathies: what should be expected?]. [Article in French] [2011]
Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data
analysis. [2011]
Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses. [2010.11]
Botulinum toxin type A in post-stroke upper limb spasticity. [2010.08]
Botulinum neurotoxin-A does not spread to distant muscles after intragastric injection: A double-blind single-fiber electromyography study. [2010.08]
Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric charcot-marie-tooth disease type 1A. [2010.08]
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. [2010.08]
Botulinum toxin A treatment in toddlers with cerebral palsy. [2010.08]
Comparison between botulinum toxin and corticosteroid injection in the treatment of acute and subacute tennis elbow: a prospective, randomized, double-blind, active drug-controlled pilot study. [2010.08]
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine. [2010.07]
Intravesical injections of botulinum toxin type A for management of neuropathic bladder: a comparison of two methods. [2010.07]
Fissurectomy combined with botulinum toxin A injection for medically resistant chronic anal fissures. [2010.07]
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. [2010.06]
Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial. [2010.05.18]
[Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury] [2010.05]
Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to onabotulinumtoxinA and task practice therapy: a single-blind, randomized controlled pilot study. [2010.05]
Clinical effectiveness of botulinum toxin A compared to a mixture of steroid and local anesthetics as a treatment for sacroiliac joint pain. [2010.05]
Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia. [2010.04]
Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study. [2010.04]
Botulinum toxin, physical and occupational therapy, and neuromuscular electrical stimulation to treat spastic upper limb of children with cerebral palsy: a pilot study. [2010.03]
Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis. [2010.03]
Botulinum toxin type A versus phenol. A clinical and neurophysiological study in the treatment of ankle clonus. [2010.03]
Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity. [2010.03]
Bilateral versus posterior injection of botulinum toxin in the internal anal sphincter for the treatment of acute anal fissure. [2010.02]
Ultrasonographic guided botulinum toxin type A treatment for plantar fasciitis: an outcome-based investigation for treating pain and gait changes. [2010.02]
Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. [2010.02]
Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. [2010.01]
Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. [2010.01]
Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. [2010.01]
Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. [2010.01]
Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study. [2010]
Goal attainment scaling in the evaluation of treatment of upper limb spasticity
with botulinum toxin: a secondary analysis from a double-blind placebo-controlled
randomized clinical trial. [2010]
Urodynamic effects of once daily tadalafil in men with lower urinary tract
symptoms secondary to clinical benign prostatic hyperplasia: a randomized,
placebo controlled 12-week clinical trial. [2010]
The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors
spasticity after stroke. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: results from the
double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. [2010]
OnabotulinumtoxinA for treatment of chronic migraine: results from the
double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. [2010]
Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a
pilot study. [2010]
Botulinum toxin type A in post-stroke upper limb spasticity. [2010]
Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin A injections in cerebral palsy children. [2009.12]
Blinded randomized clinical trial of botulinum toxin versus isosorbide dinitrate ointment for treatment of anal fissure. [2009.12]
Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. [2009.12]
An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. [2009.11]
Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study. [2009.11]
Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. [2009.10.16]
A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes. [2009.10]
Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study. [2009.10]
Botulinum toxin type A reduces histamine-induced itch and vasomotor responses in human skin. [2009.10]
Effect of Botulinum Toxin Injection on Nocturnal Bruxism: A Randomized Controlled Trial. [2009.09.26]
Comparison of pain scores with 30-gauge and 32-gauge needles for periocular botulinum toxin type a injections. [2009.09]
Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial. [2009.09]
A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke. [2009.09]
The effectiveness of botulinum A toxin as an adjunct to the treatment of clubfeet by the Ponseti method: a randomized, double blind, placebo controlled study. [2009.09]
Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity. [2009.09]
Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study. [2009.08]
Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy. [2009.06]
Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind study. [2009.01.30]
Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes. [2009.01]
Botulinum toxin as preventive treatment for migraine: a randomized double-blind study. [2009]
Well-designed clinical trials possibly related to Dysport (Botulinum Toxin Type A)
Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a
randomized, double-blinded, controlled multicentre clinical trial. [2011]
Walking ability and predictors of performance on the 6-minute walk test in adults with spastic cerebral palsy. [2010.06]
Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. [2010.04]
Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. [2009.12]
Measurement of health-related quality of life in children undergoing external fixator treatment for lower limb deformities. [2009.12]
[Does dilution have an impact on cosmetic results with BoNT/A? Complex-protein-free BoNT/A for treatment of glabella lines] [2009.10]
Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm. [2009.09]
A placebo-controlled surgical trial of the treatment of migraine headaches. [2009.08]
[Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome.] [2009.07]
Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial. [2009.01]
Other research related to Dysport (Botulinum Toxin Type A)
Quality of life in hemifacial spasm patient after treatment with botulinum toxin
A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and
Neuronox study. [2012]
Myofascial pain of the jaw muscles: comparison of short-term effectiveness of
botulinum toxin injections and fascial manipulation technique. [2012]
Effect of dietary zinc and phytase supplementation on botulinum toxin treatments. [2012]
Pain difference associated with injection of abobotulinumtoxinA reconstituted
with preserved saline and preservative-free saline: a prospective, randomized,
side-by-side, double-blind study. [2012]
Split-face double-blind study comparing the onset of action of onabotulinumtoxinA
and abobotulinumtoxinA. [2012]
Prospective randomised controlled trial comparing trigone-sparing versus
trigone-including intradetrusor injection of abobotulinumtoxinA for refractory
idiopathic detrusor overactivity. [2012]
Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity. [2011.11.07]
Botulinum Type A Toxin Complex for the Relief of Upper Back Myofascial Pain Syndrome: How Do Fixed-Location Injections Compare with Trigger Point-Focused Injections? [2011.11]
An Internally Controlled, Double-blind Comparison of the Efficacy of OnabotulinumtoxinA and AbobotulinumtoxinA. [2011.11]
Field effect of two commercial preparations of botulinum toxin type A: A prospective, double-blind, randomized clinical trial. [2011.10.29]
Time to Onset of Response of AbobotulinumtoxinA in the Treatment of Glabellar Lines: A Subset Analysis of Phase 3 Clinical Trials of a New Botulinum Toxin Type A. [2011.10]
[Use of botulinum neurotoxin therapy]. [2011.07]
Intravesical electromotive botulinum toxin type A administration: part I--Experimental study. [2011.06]
Treatment of refractory anterior knee pain using botulinum toxin type A (Dysport) injection to the distal vastus lateralis muscle: a randomised placebo controlled crossover trial. [2011.06]
[Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010]. [2011.04]
|
